3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Neoplasms
1
Interventions
Specimen Handling
198
Magnetic Resonance Spectroscopy
160
pembrolizumab
141
Carboplatin
117
Biopsy
111
Cyclophosphamide
93
Cisplatin
93
Paclitaxel
75
Bevacizumab
61
Gemcitabine
60
Nivolumab
57
fludarabine
53
Radiotherapy
50
Fluorouracil
49
Pemetrexed
46
Oxaliplatin
43
Dexamethasone
43
venetoclax
42
Rituximab
41
Leucovorin
41
Doxorubicin
41
durvalumab
40
Docetaxel
40
Capecitabine
39
Radiation
37
atezolizumab
35
Prednisone
32
Injections
31
Fulvestrant
31
Standard of Care
29
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Curcumin
×
30 days
×
Clear all
NCT06626230
2026-05-18
Safety of Anal Curcumin
Emory University
Phase 1
Recruiting
48 enrolled